Author

Vladimir Besada

Centro de Ingeniería Genética y BiotecnologíaORCID 0000-0003-3584-7714Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1

Frequent Co-Authors

Luis Javier GonzáleziD· 3 shared Arielis Rodríguez‐UlloaiD· 2 shared Dagmar García-RiveraiD· 1 shared Dania Vázquez‐BlomquistiD· 1 shared Daniel G. RiveraiD· 1 shared Darielys Santana-MederosiD· 1 shared Eva Vonasek· 1 shared Iraldo Bello RiveroiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Luis Javier GonzálezORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 24, 2026

Integrated Analysis of HeberFERON-Driven Comparative Proteomic regulation in Glioblastoma Cells U-87MG

Dania Vázquez‐Blomquist, Vladimir Besada, Jamilet Miranda…·Iraldo Bello Rivero

This study investigates proteomic changes in glioblastoma cells treated with HeberFERON compared to individual IFNs, identifying multitarget effects and potential pharmacodynamic biomarkers.

DOI 10.64898/2026.04.22.720155

humanproteomics

𝕏 PostBluesky

BiochemistryPROTEOMICSPeer-reviewedJul 1, 2025

LC-MS/MS characterization of SOBERANA(R)02, a receptor binding domain-tetanus toxoid conjugate vaccine against SARS-CoV-2

Olivia Martínez, Darielys Santana-Mederos, Satomy Pousa…·Luis Javier González

This paper characterizes the conjugation sites of a SARS-CoV-2 vaccine using LC-MS/MS and identifies 12 and 18 conjugation sites through different analytical strategies.

DOI 10.1002/pmic.13978

proteomicsexperimental assay

𝕏 PostBluesky

Cancer BiologyBiological ChemistryPeer-reviewedMar 1, 2025

Time- and Dose-dependent Effects of CIGB-300 in the lung squamous cell carcinoma proteomics.

Liudy García Hernández, Lingfeng Dai, Arielis Rodríguez‐Ulloa…·Yasser Perera

This study examines the time- and dose-dependent effects of CIGB-300 on the proteome of squamous lung cancer cells, identifying potential biomarkers and mechanisms of action.

1 citation

humanproteomics

𝕏 PostBluesky